TR201709467A2 - Ganoderma Lucidum Mushroom Component Formulation and Method for Gum Making - Google Patents
Ganoderma Lucidum Mushroom Component Formulation and Method for Gum Making Download PDFInfo
- Publication number
- TR201709467A2 TR201709467A2 TR2017/09467A TR201709467A TR201709467A2 TR 201709467 A2 TR201709467 A2 TR 201709467A2 TR 2017/09467 A TR2017/09467 A TR 2017/09467A TR 201709467 A TR201709467 A TR 201709467A TR 201709467 A2 TR201709467 A2 TR 201709467A2
- Authority
- TR
- Turkey
- Prior art keywords
- gum
- ganoderma lucidum
- added
- kneaded
- minutes
- Prior art date
Links
- 240000008397 Ganoderma lucidum Species 0.000 title claims abstract description 38
- 235000001637 Ganoderma lucidum Nutrition 0.000 title claims abstract description 35
- 239000000203 mixture Substances 0.000 title claims abstract description 16
- 235000001674 Agaricus brunnescens Nutrition 0.000 title claims abstract description 12
- 238000000034 method Methods 0.000 title claims abstract description 7
- 238000009472 formulation Methods 0.000 title claims abstract description 4
- 238000004519 manufacturing process Methods 0.000 claims abstract description 5
- 241000894007 species Species 0.000 claims abstract description 4
- 239000000284 extract Substances 0.000 claims description 18
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 14
- 235000011187 glycerol Nutrition 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 5
- 241000018646 Pinus brutia Species 0.000 claims description 5
- 235000011613 Pinus brutia Nutrition 0.000 claims description 5
- 239000003086 colorant Substances 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 4
- 239000000843 powder Substances 0.000 claims description 4
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 3
- 235000003599 food sweetener Nutrition 0.000 claims description 3
- 239000000845 maltitol Substances 0.000 claims description 3
- 235000010449 maltitol Nutrition 0.000 claims description 3
- 230000008447 perception Effects 0.000 claims description 3
- 235000010356 sorbitol Nutrition 0.000 claims description 3
- 239000000600 sorbitol Substances 0.000 claims description 3
- 239000003765 sweetening agent Substances 0.000 claims description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- 230000000845 anti-microbial effect Effects 0.000 claims description 2
- 230000000840 anti-viral effect Effects 0.000 claims description 2
- 230000009286 beneficial effect Effects 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims description 2
- 239000003906 humectant Substances 0.000 claims description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 claims description 2
- 229940035436 maltitol Drugs 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- 239000006188 syrup Substances 0.000 claims description 2
- 235000020357 syrup Nutrition 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims 4
- 241000218236 Cannabis Species 0.000 claims 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims 3
- 239000003995 emulsifying agent Substances 0.000 claims 3
- 239000004254 Ammonium phosphate Substances 0.000 claims 2
- 229920002472 Starch Polymers 0.000 claims 2
- 229910000148 ammonium phosphate Inorganic materials 0.000 claims 2
- 235000019289 ammonium phosphates Nutrition 0.000 claims 2
- 230000001055 chewing effect Effects 0.000 claims 2
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 claims 2
- 239000000796 flavoring agent Substances 0.000 claims 2
- 235000019634 flavors Nutrition 0.000 claims 2
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 claims 2
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 claims 2
- 229920005862 polyol Polymers 0.000 claims 2
- 150000003077 polyols Chemical class 0.000 claims 2
- 239000000047 product Substances 0.000 claims 2
- 239000008107 starch Substances 0.000 claims 2
- 235000019698 starch Nutrition 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 claims 1
- 240000002900 Arthrospira platensis Species 0.000 claims 1
- 235000016425 Arthrospira platensis Nutrition 0.000 claims 1
- 102000011632 Caseins Human genes 0.000 claims 1
- 108010076119 Caseins Proteins 0.000 claims 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 1
- 239000004386 Erythritol Substances 0.000 claims 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 claims 1
- 108010010803 Gelatin Proteins 0.000 claims 1
- 229920002774 Maltodextrin Polymers 0.000 claims 1
- 239000005913 Maltodextrin Substances 0.000 claims 1
- 229930195725 Mannitol Natural products 0.000 claims 1
- 244000131316 Panax pseudoginseng Species 0.000 claims 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims 1
- 235000003140 Panax quinquefolius Nutrition 0.000 claims 1
- 239000005862 Whey Substances 0.000 claims 1
- 102000007544 Whey Proteins Human genes 0.000 claims 1
- 108010046377 Whey Proteins Proteins 0.000 claims 1
- 230000001093 anti-cancer Effects 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 claims 1
- 239000007961 artificial flavoring substance Substances 0.000 claims 1
- 239000012141 concentrate Substances 0.000 claims 1
- 235000008504 concentrate Nutrition 0.000 claims 1
- 208000002925 dental caries Diseases 0.000 claims 1
- 235000019414 erythritol Nutrition 0.000 claims 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 claims 1
- 229940009714 erythritol Drugs 0.000 claims 1
- 239000012467 final product Substances 0.000 claims 1
- 229920000159 gelatin Polymers 0.000 claims 1
- 239000008273 gelatin Substances 0.000 claims 1
- 235000019322 gelatine Nutrition 0.000 claims 1
- 235000011852 gelatine desserts Nutrition 0.000 claims 1
- 235000008434 ginseng Nutrition 0.000 claims 1
- 235000012907 honey Nutrition 0.000 claims 1
- 229910052500 inorganic mineral Inorganic materials 0.000 claims 1
- 239000000905 isomalt Substances 0.000 claims 1
- 235000010439 isomalt Nutrition 0.000 claims 1
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 claims 1
- 239000000832 lactitol Substances 0.000 claims 1
- 235000010448 lactitol Nutrition 0.000 claims 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 claims 1
- 229960003451 lactitol Drugs 0.000 claims 1
- 229940035034 maltodextrin Drugs 0.000 claims 1
- 239000000594 mannitol Substances 0.000 claims 1
- 235000010355 mannitol Nutrition 0.000 claims 1
- 229960001855 mannitol Drugs 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 239000011707 mineral Substances 0.000 claims 1
- 235000010755 mineral Nutrition 0.000 claims 1
- 235000013379 molasses Nutrition 0.000 claims 1
- 229940080237 sodium caseinate Drugs 0.000 claims 1
- 229960002920 sorbitol Drugs 0.000 claims 1
- 229940082787 spirulina Drugs 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 235000015218 chewing gum Nutrition 0.000 abstract description 7
- 229940112822 chewing gum Drugs 0.000 abstract description 7
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- 241000233866 Fungi Species 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 229920000175 Pistacia lentiscus Polymers 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 2
- 206010008909 Chronic Hepatitis Diseases 0.000 description 2
- 208000007514 Herpes zoster Diseases 0.000 description 2
- 206010020751 Hypersensitivity Diseases 0.000 description 2
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 2
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 2
- OTUZGGSAOMCYNC-UHFFFAOYSA-N UNPD47180 Natural products CC1(C)C(OC(C)=O)CCC2(C)C3=CCC4(C)C(C(CCC=C(C)C(O)=O)C)CC(OC(C)=O)C4(C)C3=CCC21 OTUZGGSAOMCYNC-UHFFFAOYSA-N 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 229920001206 natural gum Polymers 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- OTUZGGSAOMCYNC-CRTLAZRUSA-N (E,6R)-6-[(3S,5R,10S,13R,14R,15S,17R)-3,15-diacetyloxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-2-enoic acid Chemical compound CC1(C)[C@@H](OC(C)=O)CC[C@]2(C)C3=CC[C@]4(C)[C@@H]([C@@H](CC\C=C(/C)C(O)=O)C)C[C@H](OC(C)=O)[C@@]4(C)C3=CC[C@H]21 OTUZGGSAOMCYNC-CRTLAZRUSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 206010002199 Anaphylactic shock Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 208000004434 Calcinosis Diseases 0.000 description 1
- 241001070941 Castanea Species 0.000 description 1
- 235000014036 Castanea Nutrition 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 229920001412 Chicle Polymers 0.000 description 1
- 244000241235 Citrullus lanatus Species 0.000 description 1
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 240000000731 Fagus sylvatica Species 0.000 description 1
- 235000010099 Fagus sylvatica Nutrition 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- OTUZGGSAOMCYNC-AEGHVTTBSA-N Ganoderic acid Me Chemical compound CC1(C)[C@H](OC(C)=O)CC[C@]2(C)C3=CC[C@]4(C)[C@@H]([C@@H](CC\C=C(/C)C(O)=O)C)C[C@H](OC(C)=O)[C@@]4(C)C3=CC[C@H]21 OTUZGGSAOMCYNC-AEGHVTTBSA-N 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 241000589989 Helicobacter Species 0.000 description 1
- 241000700721 Hepatitis B virus Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 240000001794 Manilkara zapota Species 0.000 description 1
- 235000011339 Manilkara zapota Nutrition 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241000219492 Quercus Species 0.000 description 1
- 235000016976 Quercus macrolepis Nutrition 0.000 description 1
- 201000007737 Retinal degeneration Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- JLQNHALFVCURHW-UHFFFAOYSA-N cyclooctasulfur Chemical compound S1SSSSSSS1 JLQNHALFVCURHW-UHFFFAOYSA-N 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- -1 etc.) Substances 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000008369 fruit flavor Substances 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 235000020278 hot chocolate Nutrition 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 240000004308 marijuana Species 0.000 description 1
- 231100000544 menstrual irregularity Toxicity 0.000 description 1
- 230000006371 metabolic abnormality Effects 0.000 description 1
- 239000008368 mint flavor Substances 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 210000003254 palate Anatomy 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000001012 protector Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 235000015260 sugar-free gum Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000005748 tumor development Effects 0.000 description 1
Abstract
Buluş, Ganoderma Lucidum Mantar türlerinin şekerli ve tatlandırıcılı sakız şeklinde tüketilmesini sağlayacak Ganoderma Lucidum ekstratlı sakız formülasyonu ve üretim tekniğine ait yöntemi içermektedir.The invention includes the Ganoderma Lucidum extracted chewing gum formulation and the method of its production technique that will enable the consumption of Ganoderma Lucidum Mushroom species in the form of sugar and sweetened chewing gum.
Description
TARIFNAME GANODERMA LUCIDUM MANTAR BILESENLI SAKIZ YAPIMINA AIT FORMÜLASYON VE YÖNTEM Teknik Alan Bulus, içeriginde 400'ün üstünde biyoaktif bilesene sahip ve sagliga faydalari yüzünden dünyada gittikçe yaygin halde tüketilmeye baslanan Ganoderma Lucidum mantar türlerinden en az biriyle hazirlanan toz veya sivi formdaki ekstraktlarin, sakiz ürünü bilesenlerine eklenerek yeni bir saglikli Ganoderma Lucidum'lu sakiz ürünü gelistirilmesine yöneliktir. Sekerleme sektörü içindeki sakiz ürünüyle ilgili bir bulustur. DESCRIPTION GANODERMA LUCIDUM MUSHROOM COMPONENT GUM MAKING FORMULATION AND METHOD Technical Area The invention has more than 400 bioactive components in its content and has health benefits. Ganoderma Lucidum, which is being consumed more and more in the world due to Extracts in powder or liquid form prepared with at least one of the mushroom species, chewing gum A new healthy gum product with Ganoderma Lucidum has been added to its ingredients. aimed at development. It is an invention regarding the chewing gum product within the confectionery industry.
Bulusun Altyapisi Reishi Mantari (Ganoderma Lucidum), oldukça dayanikli, odunsu bir mantar olup çok nemli, içerisine az isik giren yogun agaçli ormanlarin içinde bulunan çürümeye yüz tutmus mese, kestane, kayin, erik gibi agaç kütükleri üzerinde yetisen çok degerli bir mantardir. 4000 yildan fazla bir süredir Geleneksel Çin ve Japon tibbinda kullanilmaktadir. Invention Background Reishi Mushroom (Ganoderma Lucidum) is a very durable, woody mushroom. rotten in moist, dense wooded forests with little light. It is a very valuable tree that grows on tree stumps such as oak, chestnut, beech and plum. is a fungus. In Traditional Chinese and Japanese medicine for over 4000 years is used.
Ganoderma Lucidum'dan izole edilen polisakkaritlerin hipoglisemik (seker düsürücü) etkisi oldugu ve diabetik farelerdeki meta bolikanormallikleri düzeltip böbrek komplikasyonlarini durdugu veya ilerlemesini yavaslastigi ortaya konmustur. Hypoglycemic (sugar lowering) polysaccharides isolated from Ganoderma Lucidum It has an effect on the kidneys and corrects the metabolic abnormalities in diabetic mice. It has been shown that it stops the complications or slows the progression.
Ganoderrnik asit T ve Z karacigerde tümör gelismesini engellemektedir. Bu aktif maddelerin Hepatit B virüsüne koruyucu etki göstererek kronik hepatiti önledigi bulunmustur. Ayrica mantarlarin misellerinden elde edilen ganodermik asit R ve S ile göstermektedir. Ganodernic acid prevents tumor development in T and Z liver. this is active substances prevent chronic hepatitis by showing a protective effect against the hepatitis B virus. has been found. In addition, with ganodermic acid R and S obtained from mycelium of fungi. shows.
Ganoderma Lucidum uzak dogu ülkelerinde yüz yillar boyunca yüksek kan basincinin düsürülmesinde de kullanilmistir. Yüksek tansiona yol açan bir enzim olan anjiyontensin- dönüstüren enzimin (ACE) çalismasi Ganoderma Lucidumdan izole edilen ganodermik asit B ve D tarafindan engellenmekte bu sayede kan basinci düsebilmektedir. Antiviral etki olarak Ganoderma Lucidum Herpes zosterde (zona) agri ve derideki problemleri azaltmaktadir. Antimikrobiyal olarak insanlarda gastrit, ülser ve mide kanserine yol açan Helicobacter pylory bakterisinin büyümesini durdurdugu gözlenmistir. Astim, alerji, rometizma ve atesli hastaliklarda mast hücrelerinden asiri miktarda histamin salgilanmaktadir. Ganoderma lucidumda dogal olarak bulunan ganodermik asit A, C, D ve Cyclooctasulfur'un histamin salinimini engelleyici etkisi bulunmaktadir. Böylece Ganoderma Lucidum alerji, simse ve anaflaktik soku engellemektedir. Ganoderma Lucidum has been associated with high blood pressure for centuries in far eastern countries. It has also been used for lowering. an enzyme that causes high blood pressure study of angiotensin-converting enzyme (ACE) isolated from Ganoderma Lucidum It is inhibited by ganodermic acids B and D, thus blood pressure can fall. Ganoderma Lucidum as an antiviral effect in Herpes zoster (shingles) It reduces pain and skin problems. Gastritis in humans as an antimicrobial, the growth of the bacterium Helicobacter pylory, which causes ulcers and stomach cancer. observed to stop. Mast in asthma, allergy, rheumatism and febrile diseases An excessive amount of histamine is secreted from the cells. Natural in Ganoderma lucidum histamine release of ganodermic acids A, C, D and Cyclooctasulfur has an inhibitory effect. Thus, Ganoderma Lucidum allergy, glitter and It prevents anaphylactic shock.
Genel olarak Ganoderma Lucidum kalp, beyin, karaciger ve akciger koruyucusu olmasinin yaninda, bagisiklik sistemini de güçlendirdigi hastaliklara karsi direnci de arttirdigi, akne, adet düzensizligi, alzheimer, anoreksiya, astim, bronsit, depreyon, eklem romatizmasi, epilepsi, hemoroit, hipertansiyon, kanser, kireçlenme, kronik hepatit, katarakt, obezite, gut, nezle, rinit, retinal pigment dejenerasyonu, saç dökülmesi, nefrit, nevrastani, ülser ve uykusuzluk gibi birçok hastaligin tedavisinde etkili oldugu görülmüstür. In general, Ganoderma Lucidum is heart, brain, liver and lung protector. In addition to being strong, it also strengthens the immune system and is resistant to diseases. increased, acne, menstrual irregularity, alzheimer's, anorexia, asthma, bronchitis, depression, rheumatism, epilepsy, hemorrhoids, hypertension, cancer, calcification, chronic hepatitis, cataract, obesity, gout, cold, rhinitis, retinal pigment degeneration, hair in the treatment of many diseases such as rash, nephritis, neurastania, ulcer and insomnia. has been found to be effective.
Bütün bu faydalarina ragmen Ganoderma Lucidum'un aci tadi kullanimini kisitlamaktadir. Bu yararlarindan faydalanabilmek için birçok ürün gelistirilmis ve piyasaya sunulmustur. Despite all these benefits, the bitter taste of Ganoderma Lucidum is still used. restricts. In order to benefit from these benefits, many products have been developed and has been put on the market.
Mevcutta bulunan ürünlerde, Ganoderma Lucidum ekstrakti toz halde yutularak tüketilen “kapsül" formda sunulmustur. Fakat bu da çogu çocuk ve bazi yetiskinlerde ilaç algisi olusturdugu için tercih edilmemektedir. Sicak çikolata ve kahveli ürünlerde Ganoderma Lucidum ekstraktinda bulunan etken maddelerin sicakligin etkisiyle biyoyararliliginin azalacagi beklenmektedir. yastan insan için mantar tüketimini çekici hale getirecek, her yerde kolaylikla tasinabilip tüketilmesini saglayacak ve mantarin etken maddelerinin etkisinin sindirim sistemindeki asiri asidik ortama ugramadan agiz içindeki dokulardan vücuda geçme ihtimaliyle biyoyararliligi diger ganodermali ürünlere göre daha yüksek olacaktir. In existing products, Ganoderma Lucidum extract is swallowed in powder form. It is presented in “capsule” form that is consumed, but this is also found in most children and some adults. It is not preferred because it creates a drug perception. Hot chocolate and coffee products With the effect of temperature, the active ingredients in Ganoderma Lucidum extract Its bioavailability is expected to decrease. It will make the consumption of mushrooms attractive to people of mourning, they can be easily found everywhere. It will ensure that it can be transported and consumed and that the effect of the active ingredients of the fungus will be digested. passing from the tissues in the mouth to the body without being exposed to the extremely acidic environment in the system It is likely that its bioavailability will be higher than other ganodermic products.
Bulus, Ganoderma Lucidum ekstraktli sakiz yapimina ait yöntem, ayrica sakizin agizda kalma süresi dikkate alindiginda dis eti, damak ve disler için daha fazla koruma saglanmasina sebep olacaktir. Invention, method of making gum with Ganoderma Lucidum extract, also Considering the residence time in the mouth, more for the gums, palate and teeth. will result in protection.
Bulusun Açiklanmasi Bulus, Ganoderma Lucidum mantar türlerinin sentetik veya dogal sakiz mayasi kullanilarak sakiz seklinde tüketilmesini saglamaktadir. Söz konusu bulus, Ganoderma Lucidum türleri ekstraktinin toz veya sivi halde, enkapsüle veya enkapsüle olmamis halde; yapay sakiz mayasi veya kenger, damla sakizi, chicle, çam sakizi vb. gibi dogal sakiz mayasi ile formüle edilip, istenilen sekilde, formda yapilan ve sakiz alaninda kullanilan her türlü renk, tatlandirici(aspartame, aceculfam K), yapi saglayici( sakaroz, sorbitol, xylitol gibi bütün seker alkoller vb.), nem tutucu (gliserin, sorbitol, maltitol vb), yumusatici (glukoz surubu, maltitol surubu, gliserin vb.) ve aroma (çilek, nane, karpuz vb.) maddelerinden en az birini içeren sakiz yapimina ait yöntemi içermektedir. Disclosure of the Invention The invention is a synthetic or natural gum base of the fungal species Ganoderma Lucidum. It allows it to be consumed in the form of chewing gum. The invention in question Extract of Ganoderma Lucidum species in powder or liquid form, encapsulated or not encapsulated; artificial gum base or kenger, mastic gum, chicle, pine gum etc. It can be formulated with natural gum base like All kinds of colors, sweeteners (aspartame, aceculfam) made and used in the field of gum K), structure provider (all sugar alcohols such as sucrose, sorbitol, xylitol, etc.), humectant (glycerin, sorbitol, maltitol etc.), softener (glucose syrup, maltitol syrup, glycerin etc.) and flavoring (strawberry, mint, watermelon, etc.) contains the method.
Ganoderma Lucidum mantar katkili sakiz üretimine iliskin islem basamaklari asagidaki gibidir: Sakiz mayasi olarak Kenger sakizi kullanilarak yapilirsa: o Kenger sakizi, mikser ile 130-160 C°'deki sicaklikta 30 dakika isitilip yogrulur, o %05 ile %4 arasinda oranda gliserin kenger sakizina eklenip sicakligin 70 C°'ye sogutulmasi saglanir, 0 Otomatik veya manuel bir karistirici yardimiyla 15 dakika karistirilir, . Aroma salinimini, raf ömrünü ve aromanin algilanisini arttiran, %70 ile %85 . Yag ve su bazli ürünlerin birbirleriyle karismasini saglayip aroma kaliciliginin artmasina yardimci olan Iesitin %0.1 ile %1 arasinda oranda karisima eklenir ve 10 dakika yogrulur, yogrulur, Son olarak Ganoderma Lucidum ekstrakti %01 ila %2 oraninda olusan karisima eklenir ve 20 dakika yogrulur, Ganoderma Lucidum ekstraktli Kenger sakizina sekil verilip oda sicakliginda bir saat dinlendirilir. Process steps related to Ganoderma Lucidum mushroom-added chewing gum production as below: If made using Kenger gum as gum base: o Kenger gum is heated and kneaded with a mixer at a temperature of 130-160 C° for 30 minutes, o Between 05% and 4% of glycerine is added to the cannabis gum and the temperature is set to 70 It is provided to be cooled to C°, 0 It is mixed for 15 minutes with the help of an automatic or manual mixer, . 70% to 85%, increasing aroma release, shelf life and aroma perception. . It ensures the mixing of oil and water-based products with each other and ensures the permanence of the aroma. It is added to the mixture at a rate of between 0.1% and 1%, which helps to increase and kneaded for 10 minutes, is kneaded, Finally, Ganoderma Lucidum extract is composed of 01 to 2%. added to the mixture and kneaded for 20 minutes, Kenger gum with Ganoderma Lucidum extract was shaped and kept at room temperature. one hour rest.
Sentetik sakiz mayasi veya damla sakizi veya çam sakizi kullanilarak sekerli sakiz yapilirsa: Sakiz mayasi. mikser ile 50 ila 80 C° arasindaki sicaklikta 30 dakika isitilip yogrulur, Kurumayi önlemek amaçli %0.1-2 arasi oranda gliserin ve yumusatici amaçli sicaklikta yogrulur, sicaklikta yogrulur, Yag ve su bazli ürünlerin birbirleriyle karismasini saglayan Iesitin %0.1 ile %1 arasi oranda karisima eklenir ve 10 dakika yogrulur, dakika yogrulur, Son olarak Ganoderma Lucidum ekstrakti %01 ila %2 oraninda olusan karisima eklenir ve 20 dakika yogrulur, Ganoderma Lucidum ekstraktli sekerli sakiza sekil verilip oda sicakliginda bir saat dinlendirilir. Using synthetic gum base or mastic gum or pine gum If sugared gum is made: Gum base. heated with a mixer at a temperature between 50 and 80 °C for 30 minutes. is kneaded, 0.1-2% glycerin to prevent drying and softener kneaded in heat, kneaded in heat, Iesit, which allows oil and water-based products to mix with each other, is between 0.1% and 1%. It is added to the mixture at a rate of .0 and kneaded for 10 minutes, minutes are kneaded, Finally, Ganoderma Lucidum extract is composed of 01% to 2%. added to the mixture and kneaded for 20 minutes, Ganoderma Lucidum extract candied chewing gum is shaped and prepared at room temperature. the clock rests.
Yapay sakiz mayasi veya damla sakizi veya çam sakizi kullanilarak Sakiz mayasi, mikser ile 50 ila 80 C° arasindaki sicaklikta 30 dakika isitilip yogrulur, o Kurumayi önlemek amaçli %0.1-7 arasi oranda gliserin ve yumusatici amaçli sicaklikta yogrulur, ) karisima eklenir ve 10 dakika ayni sicaklikta yogrulur, o Yag ve su bazli ürünlerin birbirleriyle karismasini saglayan Iesitin %0.1 ile %2 arasi oranda karisima eklenir ve 10 dakika yogrulur, o %075 ile %3 arasi oranda meyve veya nane aromaiari karisima eklenir ve 10 dakika yogrulur, o %0.01-O.5 oraninda tatlandirici (aspaitame, aceculfam K) karisima eklenir ve dakika yogrulur, 0 Son olarak Ganoderma Lucidum ekstrakti %0.1 ila %2 oraninda olusan karisima eklenir ve 20 dakika yogrulur, o Ganoderma Lucidum ekstraktli sekersiz sakiza sekil verilip oda sicakliginda bir saat dinlendirilîr. Using artificial gum base or mastic gum or pine gum The gum base is heated with a mixer at a temperature between 50 and 80 °C for 30 minutes. is kneaded, o 0.1-7% glycerin and softener to prevent drying kneaded in heat, ) is added to the mixture and kneaded at the same temperature for 10 minutes, o Between 0.1% and 2% of Ielite, which allows oil and water-based products to mix with each other. It is added to the mixture at a rate of .0 and kneaded for 10 minutes, o Between 075% and 3% fruit or mint flavors are added to the mixture and 10 minutes are kneaded, o 0.01-0.5% of sweetener (aspaitame, aceculfam K) is added to the mixture and minutes are kneaded, 0 Finally, Ganoderma Lucidum extract is composed of 0.1% to 2%. added to the mixture and kneaded for 20 minutes, o Sugar-free gum with Ganoderma Lucidum extract is shaped and prepared at room temperature. the clock rests.
Söz konusu bulus, Ganoderma Lucidum mantar türlerinin vücuda alinimini kolaylastirmak ve insan sagligi üzerinde olumlu etkilerinden daha genis kitlelerin faydalanabilmesi için gelistirilmistir. Birçok hastaliga faydali olmasi sayesinde insan tüketimi için önemli olmaktadir. The present invention shows the ingestion of Ganoderma Lucidum fungal species. to facilitate and benefit the wider masses from its positive effects on human health. developed for its use. Thanks to the fact that it is beneficial for many diseases, human important for consumption.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2017/09467A TR201709467A2 (en) | 2017-06-28 | 2017-06-28 | Ganoderma Lucidum Mushroom Component Formulation and Method for Gum Making |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2017/09467A TR201709467A2 (en) | 2017-06-28 | 2017-06-28 | Ganoderma Lucidum Mushroom Component Formulation and Method for Gum Making |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201709467A2 true TR201709467A2 (en) | 2018-01-22 |
Family
ID=67980363
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2017/09467A TR201709467A2 (en) | 2017-06-28 | 2017-06-28 | Ganoderma Lucidum Mushroom Component Formulation and Method for Gum Making |
Country Status (1)
Country | Link |
---|---|
TR (1) | TR201709467A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11439676B2 (en) * | 2018-10-16 | 2022-09-13 | Kaeco Group, Inc. | Method for prevention or treating gastrointestinal distress in humans using mastic gum compositions |
-
2017
- 2017-06-28 TR TR2017/09467A patent/TR201709467A2/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11439676B2 (en) * | 2018-10-16 | 2022-09-13 | Kaeco Group, Inc. | Method for prevention or treating gastrointestinal distress in humans using mastic gum compositions |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103977056A (en) | Compound rhodiola rosea chewing tablet and preparing method thereof | |
CN103704548B (en) | A kind of xylitol root of kudzu vine jelly and preparation method thereof | |
KR102146637B1 (en) | Cookie manufacturing method containing citron leaf powder and cookies produced by | |
KR101689652B1 (en) | Drink composition having improved storage stability and the method thereof | |
CN106616183B (en) | Solid beverage composition with maca and dandelion as main flavor agents and preparation method thereof | |
CN102919499B (en) | Sugar-free health care chewing gum | |
KR101845388B1 (en) | Beverage composition with the extract of aged onion and the concentrate of wild genseng fruit | |
CN105941816A (en) | Chewing gum with healthcare functions and cyclocarya paliurus | |
KR101333152B1 (en) | Honey containing lavender | |
KR102202102B1 (en) | Manufacturing method of macaron containing fruit of medicinal crop and macaron containing fruit of medicinal crop manufactured by the same | |
CN105056096A (en) | Wine capable of tonifying kidney and promoting blood circulation to remove meridian obstruction, and preparation method thereof | |
TR201709467A2 (en) | Ganoderma Lucidum Mushroom Component Formulation and Method for Gum Making | |
CN104041649A (en) | Breath-freshening and throat-wetting sugar containing Chinese medicinal herb extracts and preparation method of breath-freshening and throat-wetting sugar | |
KR101181949B1 (en) | A manufacturing method of dried red ginseng for prevention of sleepiness and dried red ginseng for prevention of sleepiness manufactured by the same | |
CN111567797A (en) | Compound jasmine tea chewable tablet and preparation method thereof | |
KR102054125B1 (en) | A method for manufacturing low temperature aging garlic and composition for antifatigue comprising there of extract | |
KR100503974B1 (en) | Confectionery and Korean sweet cookies manufacturing method using velvet antlers | |
KR20070047396A (en) | A functional beverage using hericium erinaceus extracts and manufacturing process of the same | |
KR102151925B1 (en) | Cookie manufacturing method containing chongmyong tee and cookies produced by | |
KR20140076260A (en) | Sweet jelly of red beans using a jujube and a method of there of | |
FR3070261A1 (en) | COMBINATION PRODUCT FOR RELIEVING SYMPTOMS ASSOCIATED WITH HIGHER RESPIRATORY TRACT INFECTIONS | |
CN105285991A (en) | Ginseng royal jelly nanometer powder buccal tablets and preparation method thereof | |
KR20180053015A (en) | Red Ginseng Processed Foods | |
KR20220090184A (en) | Method Manufacturing for health food sung cola nut and jelly type health food using the method | |
RU2537902C2 (en) | Rock candy |